Related Experiment Video
Updated: Feb 24, 2026

07:07
Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
Published on: February 14, 2025
3.9K
Hypoxia imaging in cells and tumor tissues using a highly selective fluorescent nitroreductase probe
Dan Yang1, Hang Yu Tian2, Tie Nan Zang1
1College of Chemical Science and Engineering, Yunnan University, Kunming, 650091, PR China.
Scientific Reports
|August 25, 2017
Summary
A novel fluorescent probe effectively detects nitroreductase (NTR) in hypoxic solid tumors. This probe shows potential for in vivo imaging and accurate tumor hypoxia diagnosis.
Area of Science:
- Biomedical Engineering
- Molecular Imaging
- Cancer Diagnostics
Background:
- Hypoxia is prevalent in advanced solid tumors due to oxygen supply-demand imbalance.
- Increased nitroreductase (NTR) expression is observed in hypoxic tumors.
- Targeting NTR is crucial for developing selective hypoxia detection probes.
Purpose of the Study:
- To design and evaluate a novel fluorescent probe for selective NTR detection.
- To assess the probe's efficacy for in vitro and in vivo hypoxia imaging.
- To demonstrate the probe's potential in cancer diagnostics.
Main Methods:
- Synthesis and characterization of a novel fluorescent probe (1).
- In vitro evaluation of probe response to NTR using rat liver microsomes.
- In vivo imaging in Caenorhabditis elegans (C. elegans) models.
- Hypoxia detection in HI5 cells and a murine tumor model.
Main Results:
- Probe (1) exhibited NTR-catalyzed reduction, leading to fluorescence enhancement.
- Selective fluorescence increase was observed due to NTR-mediated bond cleavage.
- Successful in vitro and in vivo detection of NTR and hypoxia was achieved.
- Probe (1) demonstrated efficacy in cell and animal models.
Conclusions:
- The developed fluorescent probe enables selective optical detection of NTR.
- Probe (1) is effective for in vivo imaging and diagnosing tumor hypoxia.
- This probe holds significant potential for fluorescence bioimaging and clinical applications.

